Table 3.
n | V0.5, mV | k, mV | |
---|---|---|---|
Control, f∞-V | 15 | −30.3 (0.5) | 7.5 (0.4) |
30 µM DHEA | 15 | −36.2 (0.5)* | 7.2 (0.5) |
Control, f∞-HP | 9~15 | −41.8 (0.1) | 6.0 (0.1) |
10 µM DHEA | 9~15 | −43.4 (0.5)* | 6.4 (0.4) |
30 µM DHEA | 9~15 | −46.3 (0.5)* | 6.3 (0.5) |
100 µM DHEA | 9~15 | −52.4 (0.7)* | 6.5 (0.9) |
Control, f∞-V | 15 | −28.9 (0.5) | 7.7 (0.4) |
GDP-β-S, f∞-V | 7 | −23.1 (0.5)* | 7.9 (0.4) |
Mean (SD) values were obtained by fitting plot with 5 points for holding potential (HP)-dependent steady-state inactivation curves (f∞-HP) and 13 points for quasi-steady-state inactivation curves (f∞-V); n, number of cells. V0.5, voltage that causes a 50% reduction in the amplitude of the inactivating component of L-type Ca2+ current; k, slope factor. Statistical comparison in the absence and presence of dehydroepiandrosterone (DHEA) and control versus guanosine 5′-O-(2-thiodiphosphate) (GDP-β-S) was performed using ordinary one-way ANOVA followed by Dunnet’s test.
P < 0.001 compared with control.